Tradestie Institutional Equity Comparison Engine

EQ vs CABA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Momentum & Technical, Options & Structure. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus CABA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against CABA sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs CABA N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY -52.3% vs +0.0%
Momentum & Technical Winner EQ
1Y +12.0% vs -56.8% ยท 52W Pos 11% vs 1%
Options & Structure Winner EQ
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (32nd %ile IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
CABA NASDAQ
Cabaletta Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.01
-4.27% 1D
Market Cap $227.6M
1M Return -34.42%
1Y Return -56.84%
Forward P/E N/M
Unified AI Score
46.9 / 100 HOLD
Tech 35.0 Fund 51.0 Flow 64.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +12.0% CABA -56.84% Spread: +68.84 pp (EQ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EQ TTM Op. Margin: 0.0% CABA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EQ vs CABA. Trailing 12-month operating profitability (EQ 0.0% vs CABA 0.0%) and valuation multiples (EQ 1.5x vs CABA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (6) vs CABA (2)
Institutional Metric EQ CABA Criterion Row Winner
Market Capitalization Scale $90.6M $227.6M Larger Scale CABA
Trailing P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% +0.0% Higher Growth CABA
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.0% -89.5% Higher ROE EQ
52-Week Range Position Momentum 11% ($1โ€“$4) 1% ($1โ€“$4) Stronger Trend EQ
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 93% Vol 1.94ฮฒ ยท 102% Vol Lower Realized Risk EQ
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 46.9 / 100 (HOLD) Higher Composite EQ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs CABA Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CABA BREAKDOWN
138d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CABA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor CABA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.